699016-40-5 Usage
Uses
Used in Pharmaceutical Industry:
2-FLUORO-4-IODOBENZALDEHYDE is used as an intermediate in the synthesis of drugs and other bioactive compounds, contributing to the development of new medications and therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical sector, 2-FLUORO-4-IODOBENZALDEHYDE serves as a key intermediate in the production of various agrochemicals, potentially enhancing crop protection and management strategies.
Used in Organic Synthesis:
2-FLUORO-4-IODOBENZALDEHYDE is utilized as a versatile intermediate in organic synthesis, facilitating the creation of a wide range of organic compounds for diverse applications.
Used as a Reagent in Chemical Reactions:
2-FLUORO-4-IODOBENZALDEHYDE also functions as a reagent in multiple chemical reactions, further expanding its utility across various industries that rely on chemical processes for their products or operations.
Check Digit Verification of cas no
The CAS Registry Mumber 699016-40-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,9,9,0,1 and 6 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 699016-40:
(8*6)+(7*9)+(6*9)+(5*0)+(4*1)+(3*6)+(2*4)+(1*0)=195
195 % 10 = 5
So 699016-40-5 is a valid CAS Registry Number.
InChI:InChI=1/C7H4FIO/c8-7-3-6(9)2-1-5(7)4-10/h1-4H
699016-40-5Relevant academic research and scientific papers
SUBSTITUTED HYDANTOINS
-
Page/Page column 10-11, (2009/07/17)
The present invention relates to compounds of the formula methods for the preparation thereof, and methods for their use. The compounds are useful in treating diseases characterized by the hyperactivity of MEK. Accordingly the compounds are useful in the treatment of diseases, such as cancer, cognitive and CNS disorders, and inflammatory/autoimmune diseases.
Aminoalcohol derivatives
-
Page/Page column 43-44, (2010/02/07)
The present invention relates to a compound formula [I]: wherein R1 is hydrogen or halogen, R2 is hydrogen or an amino protective group, R3 is hydrogen or lower alkyl, X is bond, —CH2— or —O—, and Y is ?in which R4 is lower alkoxycarbonyl, ?in which R5 is carboxy(lower)alkyl, etc., ?in which R6 is hydroxy, etc., and so on, or a salt thereof. The compound [I] of the present invention and pharmaceutically acceptable salts thereof are useful for the prophylactic and/or the therapeutic treatment of pollakiurea or urinary incontinence.
